info@synchemia.com | sales@synchemia.com 
9766925136 
N-Nitroso Edoxaban Impurity 1
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142659 |
| CAS No | NA |
| Mol.F. | C7H7ClN4O6S2 |
| Mol.Wt. | 342.73 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142660 |
| CAS No | NA |
| Mol.F. | C17H14N6O2 |
| Mol.Wt. | 334.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142661 |
| CAS No | NA |
| Mol.F. | C28H20ClF3N8O2 |
| Mol.Wt. | 592.97 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142662 |
| CAS No | NA |
| Mol.F. | C29H23F3N8O2 |
| Mol.Wt. | 572.55 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142663 |
| CAS No | NA |
| Mol.F. | C18H15N5O3 |
| Mol.Wt. | 349.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142664 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O2 |
| Mol.Wt. | 558.53 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142665 |
| CAS No | NA |
| Mol.F. | C20H18F3N7O2 |
| Mol.Wt. | 445.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142666 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O3 |
| Mol.Wt. | 574.52g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142667 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O4 |
| Mol.Wt. | 590.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142668 |
| CAS No | NA |
| Mol.F. | C19H19N5O2 |
| Mol.Wt. | 349.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142669 |
| CAS No | NA |
| Mol.F. | C37H27F3N12O2 |
| Mol.Wt. | 728.70 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142670 |
| CAS No | NA |
| Mol.F. | C28H21F3N8O3 |
| Mol.Wt. | 574.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142671 |
| CAS No | NA |
| Mol.F. | C19H14F3IN4O2 |
| Mol.Wt. | 514.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142672 |
| CAS No | NA |
| Mol.F. | C21H21N5O3 |
| Mol.Wt. | 391.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142673 |
| CAS No | NA |
| Mol.F. | C15H11N3O3 |
| Mol.Wt. | 281.27 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142674 |
| CAS No | NA |
| Mol.F. | C15H14ClN3O2 |
| Mol.Wt. | 303.75 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
